186 related articles for article (PubMed ID: 12239157)
1. The antiapoptosis protein survivin is associated with cell cycle entry of normal cord blood CD34(+) cells and modulates cell cycle and proliferation of mouse hematopoietic progenitor cells.
Fukuda S; Foster RG; Porter SB; Pelus LM
Blood; 2002 Oct; 100(7):2463-71. PubMed ID: 12239157
[TBL] [Abstract][Full Text] [Related]
2. Elevation of Survivin levels by hematopoietic growth factors occurs in quiescent CD34+ hematopoietic stem and progenitor cells before cell cycle entry.
Fukuda S; Pelus LM
Cell Cycle; 2002; 1(5):322-6. PubMed ID: 12461294
[TBL] [Abstract][Full Text] [Related]
3. Survivin regulates hematopoietic progenitor cell proliferation through p21WAF1/Cip1-dependent and -independent pathways.
Fukuda S; Mantel CR; Pelus LM
Blood; 2004 Jan; 103(1):120-7. PubMed ID: 12969960
[TBL] [Abstract][Full Text] [Related]
4. Regulation of the inhibitor-of-apoptosis family member survivin in normal cord blood and bone marrow CD34(+) cells by hematopoietic growth factors: implication of survivin expression in normal hematopoiesis.
Fukuda S; Pelus LM
Blood; 2001 Oct; 98(7):2091-100. PubMed ID: 11567995
[TBL] [Abstract][Full Text] [Related]
5. [Expression of survivin in cord blood CD34(+) stem/progenitor cells and its significance].
Ma YP; Zou P; Xiao J; Huang SA
Zhonghua Xue Ye Xue Za Zhi; 2003 May; 24(5):238-40. PubMed ID: 12859873
[TBL] [Abstract][Full Text] [Related]
6. Flt3 ligand and the Flt3 receptor regulate hematopoietic cell migration by modulating the SDF-1alpha(CXCL12)/CXCR4 axis.
Fukuda S; Broxmeyer HE; Pelus LM
Blood; 2005 Apr; 105(8):3117-26. PubMed ID: 15618475
[TBL] [Abstract][Full Text] [Related]
7. Contribution of STAT3 to the activation of survivin by GM-CSF in CD34+ cell lines.
Gu L; Chiang KY; Zhu N; Findley HW; Zhou M
Exp Hematol; 2007 Jun; 35(6):957-66. PubMed ID: 17533050
[TBL] [Abstract][Full Text] [Related]
8. Thrombopoietin, but not cytokines binding to gp130 protein-coupled receptors, activates MAPKp42/44, AKT, and STAT proteins in normal human CD34+ cells, megakaryocytes, and platelets.
Majka M; Ratajczak J; Villaire G; Kubiczek K; Marquez LA; Janowska-Wieczorek A; Ratajczak MZ
Exp Hematol; 2002 Jul; 30(7):751-60. PubMed ID: 12135673
[TBL] [Abstract][Full Text] [Related]
9. FLT3 ligand preserves the uncommitted CD34+CD38- progenitor cells during cytokine prestimulation for retroviral transduction.
Nielsen SD; Husemoen LL; Sørensen TU; Gram GJ; Hansen JE
J Hematother Stem Cell Res; 2000 Oct; 9(5):695-701. PubMed ID: 11091493
[TBL] [Abstract][Full Text] [Related]
10. MEK-ERK pathway is expressed but not activated in high proliferating, self-renewing cord blood hematopoietic progenitors.
Bonati A; Lunghi P; Gammaitoni L; Pinelli S; Ridolo E; Dall'Aglio PP; Piacibello W; Aglietta M
Hematol J; 2002; 3(2):105-13. PubMed ID: 12032872
[TBL] [Abstract][Full Text] [Related]
11. [Factors regulating expression of antiapoptosis gene survivin].
Xue J; Lin MF
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2005 Dec; 13(6):969-74. PubMed ID: 16403261
[TBL] [Abstract][Full Text] [Related]
12. [Expansion of erythroid progenitors and CD34+ cells by umbilical cord blood mononuclear cells].
Zhang JX; Mao P
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2005 Jun; 13(3):429-33. PubMed ID: 15972135
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of a cytokine combination including thrombopoietin for improved transduction of a retroviral gene into G-CSF-mobilized CD34+ human blood cells.
Kim HJ; Okamoto Y; Ito M; Takaue Y; Kawano Y; Watanabe T; Yamaue T; Tohda Y; Ogose T; Shimada T; Shimosaka A; Kuroda Y
Stem Cells; 1997; 15(5):347-52. PubMed ID: 9323796
[TBL] [Abstract][Full Text] [Related]
14. Expression of FLT3 receptor and response to FLT3 ligand by leukemic cells.
Drexler HG
Leukemia; 1996 Apr; 10(4):588-99. PubMed ID: 8618433
[TBL] [Abstract][Full Text] [Related]
15. Down-regulation of survivin in nitric oxide-induced cell growth inhibition and apoptosis of the human lung carcinoma cells.
Chao JI; Kuo PC; Hsu TS
J Biol Chem; 2004 May; 279(19):20267-76. PubMed ID: 14988404
[TBL] [Abstract][Full Text] [Related]
16. Ex vivo expansion of CD34+ umbilical cord blood cells in a defined serum-free medium (QBSF-60) with early effect cytokines.
Qiu L; Meagher R; Welhausen S; Heye M; Brown R; Herzig RH
J Hematother Stem Cell Res; 1999 Dec; 8(6):609-18. PubMed ID: 10645768
[TBL] [Abstract][Full Text] [Related]
17. Efficient adenoviral vector transduction of human hematopoietic SCID-repopulating and long-term culture-initiating cells.
Fan X; Brun A; Segrén S; Jacobsen SE; Karlsson S
Hum Gene Ther; 2000 Jun; 11(9):1313-27. PubMed ID: 10890741
[TBL] [Abstract][Full Text] [Related]
18. Thrombopoietin augments ex vivo expansion of human cord blood-derived hematopoietic progenitors in combination with stem cell factor and flt3 ligand.
Ohmizono Y; Sakabe H; Kimura T; Tanimukai S; Matsumura T; Miyazaki H; Lyman SD; Sonoda Y
Leukemia; 1997 Apr; 11(4):524-30. PubMed ID: 9096693
[TBL] [Abstract][Full Text] [Related]
19. MAP kinase activation by mu opioid receptor in cord blood CD34(+)CD38(-) cells.
Rozenfeld-Granot G; Toren A; Amariglio N; Nagler A; Rosenthal E; Biniaminov M; Brok-Simoni F; Rechavi G
Exp Hematol; 2002 May; 30(5):473-80. PubMed ID: 12031654
[TBL] [Abstract][Full Text] [Related]
20. Oligodeoxynucleotides antisense to c-abl specifically inhibit entry into S-phase of CD34+ hematopoietic cells and their differentiation to granulocyte-macrophage progenitors.
Rosti V; Bergamaschi G; Lucotti C; Danova M; Carlo-Stella C; Locatelli F; Tonon L; Mazzini G; Cazzola M
Blood; 1995 Nov; 86(9):3387-93. PubMed ID: 7579442
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
